Erschienen in:
01.05.2012 | Original Article
Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells
verfasst von:
Yong-sheng Yu, Zheng-hao Tang, Qing-chun Pan, Xiao-hua Chen, Xue-ni Liu, Guo-qing Zang
Erschienen in:
Cancer Chemotherapy and Pharmacology
|
Ausgabe 5/2012
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Csn3 (or CSN3) encodes the third subunit of an eight-subunit complex, the COP9 signalosome (CSN), which acts as a protein kinase and a deneddylase in mammalian cells. Previous studies have shown that Csn3 is essential for maintenance of cell proliferation in the mouse embryonic epiblast and associated with the tumorigenesis process in osteosarcoma. However, its correlation with hepatocellular carcinoma (HCC) has not been explored yet.
Methods
The expression of Csn3 in HCC (n = 30), cirrhosis (n = 30), and normal tissues (n = 30) was detected using immunohistochemical analysis. The impacts of lentivirus-mediated inhibition of Csn3 on HCC cells were detected using MTT, BrdU incorporation assay, and flow cytometric analysis. In addition, the colony formation and tumor growth ability in nude mice were detected to define the role of Csn3 in tumorigenesis.
Results
Knockdown of Csn3 expression in HCC cell lines (SMMC-7721 and Hep3B) significantly inhibits the tumor growth both in vitro and in vivo. Further investigation indicates that this growth inhibition effect may be mediated through cell cycle arrest in G0/G1 phase and inductions of pro-apoptotic proteins BIK and Caspase-8. In addition, knockdown of Csn3 expression evidently suppresses tumor growth in a xenograft nude mice model.
Conclusion
Collectively, this study demonstrates Csn3 as an oncogene that regulates the tumorigenesis process in HCC cells.